Thornberry grew up in South Bend, Indiana and did a BSc in Natural Sciences at Muhlenberg College in Allentown, Pennsylvania, She joined Merck Research Laboratories as a biochemist in 1979 and became the director of enzymology in 1990
GLP-1 receptor agonists typically reduce triglycerides by 10-20% in clinical studies
Fillers deliver results right away, while Sculptras benefits build over time
Ongoing clinical trials in peripheral vascular disease, neuropsychiatric and substance use disorders, metabolic liver disease, arthritis, hypertension and neurodegenerative disorders may broaden indications for GLP-1-based therapeutics
Injecting into muscle
58,59 Overall, the future research direction of GLP-1RAs involves making them more similar to those in the human body, extending their duration of action, and creating oral formulations for easier administration